NERVGEN PHARMA

nervgen-pharma-logo

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases. The company's lead compound, NVG-291, has placed ahead for both spinal cord injury and multiple sclerosis. The company plans to initiate a Phase 1 human clinical trial on healthy subjects in early 2020 with an expansion of the trial in the second half of 2020 to include a cohort of spinal cord injury patients. In addition, the company intends to commence a Phase 2 multiple sclerosis clinical trial in early 2021.
#SimilarOrganizations #People #Financial #Website #More

NERVGEN PHARMA

Social Links:

linkedin

Linkedin

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2017-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.nervgen.com

Total Employee:
11+

Status:
Active

Contact:
6047225361

Total Funding:
32.55 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics


Similar Organizations

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

paxvax-logo

PaxVax

PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

william-joseph-radvak_image

William Joseph Radvak Chairman @ NervGen Pharma
Board_member
2018-06-01

harold-martin-punnett_image

Harold Martin Punnett Director @ NervGen Pharma
Board_member
2017-01-01

not_available_image

Adam Rogers Board of Directors @ NervGen Pharma
Board_member
2022-07-14

brian-mcalister_image

Brian McAlister Advisor @ NervGen Pharma
Advisor
2017-01-01

Current Employees Featured

bill-adams_image

Bill Adams
Bill Adams Chief Financial Officer @ NervGen Pharma
Chief Financial Officer
2020-02-01

dan-mikol_image

Dan Mikol
Dan Mikol Chief Medical Officer @ NervGen Pharma
Chief Medical Officer

paul-brennan_image

Paul Brennan
Paul Brennan President & Chief Executive Officer @ NervGen Pharma
President & Chief Executive Officer

Founder


brian-mcalister_image

Brian McAlister

harold-martin-punnett_image

Harold Martin Punnett

william-joseph-radvak_image

William Joseph Radvak

Stock Details


Company's stock symbol is OTCQB:NGENF

Investors List

pfp-biosciences_image

PFP Biosciences

PFP Biosciences investment in Post-IPO Equity - NervGen Pharma

csbio_image

CSBio

CSBio investment in Post-IPO Equity - NervGen Pharma

Official Site Inspections

http://www.nervgen.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.75 K

  • Host name: ec2-52-35-189-246.us-west-2.compute.amazonaws.com
  • IP address: 52.35.189.246
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...

More informations about "NervGen Pharma" on Search Engine

dfkcompany.com © 2022. All rights reserved